Prescription Drug Case Study

Prescription drug abuse in the United States has officially been declared an epidemic by the Centers for Disease Control and Prevention (Prescription Drug Abuse Statistics, 2013). Due to the increase of prescription drug abuse, prescription narcotics have been considered the new “gateway” drug to heroin addiction. The prescription drug epidemic is being fueled by prescribers and physicians that are not utilizing proper guidelines when prescribing narcotics to patients. A major concern is that doctors are shying away from utilizing therapy and counseling, which could alleviate the use and abuse of prescription medication. With the increase of prescription medication flooding the population, this has lead to society’s concern that doctors are

The effect of Lobbyist in a democratic society is substantial, in both their economic and political power to sway votes in their favor. Throughout the history of Texas government these entities, both corporations, and people have seen their influential muscle flexed throughout the city of Austin. Examining how and why these groups exist, as well as in what manner they go about making money and contributing money to causes that they deem important. Gives a good insight into what exactly makes this world so appealing to all involved. After taking a look at the way, these lobbyists come to survive and thrive. A look at how one man and his backing help keep an entire pharmaceutical company in the position of running a monopoly. This man is named

In spite of that, barriers to entry in an oligopoly market are high. The prime barriers are economies of scale, access to costly and sophisticated technology, patents and tactical measures by existing dominating firms devised to hinder new firms from entering the market. In addition, other sources of barriers include government regulation favoring incumbent firms making it difficult for nascent firms to

Merck has a few weaknesses to consider such as the various controversies they have had in the past. One example is the product of VIOXX, which had risks of heart attacks and strokes and several people were injured and died using the drug. There has also been limited reports of confidence to the investors of the firm. The liquidity of the company is also low and expenses on research are very high. This makes it a key concern when developing the product because there will be a large amount of research involved in developing SafePet. In the past, Merck has faced serious government charges due to violations of rules and regulations. This makes for large expenses on paying fines and court charges. This is a key weakness when considering this company for the development of SafePet injection as funding will be needed. Another key weakness for SafePet is that the injection will have to be given at a veterinary hospital. This may make it an inconvenience for on-the-go pet owners. However, the product will be designed like other flea and tick products, meaning they will not require an exam for the injection (Haseeb, 2016).

The Orphan Drug Act of 1983 was signed for the main purpose of promoting the research, treatment, prevention and diagnosis of rare disease or condition. Here the products which are used in rare disease can be drugs, biologics and medical devices. A rare disease means any disease which affects less than 200,000 persons in the United States or one in which the manufacturer has no expectation of recovering the money from development and sales in the United States. According to this act, there are certain incentives will be provided to the manufacturers who will develop orphan drug for the rare disease and condition. Thus, this act can encourage the treatment for rare disease. The advantages of this act is that the total time for approval of

This section’s goal is to show the effectiveness and efficiency of 4 studies on the previously outlined programs. To begin, Federal funds paid for a study named The Multi-Site Adult Drug Court Evaluation (MADCE), the study measures the effectiveness of adult drug courts. Since drug courts aim at keeping addicts away from drugs and out of jail, the purpose of the study was to “evaluate the effects of drug courts on substance use, crime, and other practices,” and to note when outcomes proved positive (Rossman, Rempel, Roman, Zweig, Lindquist, Green, Downey, Yahner, Bhati, Farole, Jr., 2011, p. 1). Authors of the report include Shelli B. Rossman, Michael Rempel, John K. Roman, Janine M. Zweig, Christine H.

Janssen is one of the world’s leading research based pharmaceutical organisations and is part of the Johnson and Jonson family of companies. J&J is a diverse group of healthcare specialists. Johnson and Johnson was founded in 1886 and is an American pharmaceutical, medical devices and consumer packages goods manufacture. Janssen Pharmaceutical Companies of Johnson & Johnson, is dedicated to research and development of new drugs against the most important unmet medical needs of this generation, including oncology, infectious disease, neuroscience, cardiovascular and metabolic diseases and immunology.

The latter decade of the 20th century brought a number of major innovations to the pharmaceutical industry, most notably a remarkable wave of successful joint ventures and mergers between big and medium players in the market.

Hydrocodone and hydrocodone combination medications were rescheduled from Schedule III controlled substance to Schedule II controlled substances on October 6, 2014. This shift brought about several changes in prescribing practices and has produced several issues for patients who require pain control. Hydrocodone and hydrocodone combinations products should be reclassified as Schedule III controlled substances because patients who truly need this type of pain medication are being denied adequate pain control, in some states mid-level practitioners are no longer able to prescribe these medications, and emergency room physicians often avoid prescribing them even to those who present with obviously painful injuries or conditions.

Marty Smith is a 67-year-old male who has called 911 after experiencing chest pain and dizziness. The paramedics arrive and notice a bottle of nitroglycerin on the table. The patient states he has angina and is to take the medication as needed for chest pain. He took one pill an hour ago and a second pill 10 minutes prior to calling 911. Prior to this evening’s chest pain, he ate at a buffet and consumed 4 whiskey drinks. His ECG is not indicative of a myocardial infarction.

Across the world abusing prescription drugs causes more deaths than street drugs do combined (“International Statistics”). Prescription drugs are so easy to get ahold of and so easy to get addicted to. The misuse of prescription drugs have gotten out of hand. These drugs can cause unintentional overdoses easily. The misuse of prescription drugs can lead to addiction, affect the health of users in a dramatic way, and even cause death.

One of many important aspects of a medication history is determining how knowledgeable a patent is about their medications and their disease states. For the medication knowledge I feel that this means that the patient can identify which drug treats which disease state, how to correctly use the drug and how often, and when to get help if experiencing side effects or if

Threat of substitutes (low): This is one of the great advantages of the pharma industry. Because the demand for pharma products continues and the industry flourish. One of the main reasons for high competitiveness in the field is that it is an ongoing

Competitive rivalry: The pharmaceutical industry is highly fragmented with almost 3,000 pharma companies and 10,500 manufacturing units. Due to increasing demand of high-quality drugs, low-to-moderate entry barrier to the new entrant, the presence of a number of large and small firm this market is highly competitive. With more drugs going off - patent, growth opportunities for the industry are expected to increase dramatically as generic

Swelling government regulations in Pharmaceutical industryIt was difficult to enter the industry(high entry barrier, not lucrative)Existing players diversifying globally Require additional HR